Selasa, 12 Juni 2012

Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Due to the fact that e-book Developability Of Biotherapeutics: Computational ApproachesFrom CRC Press has excellent advantages to review, lots of people now grow to have reading habit. Sustained by the established technology, nowadays, it is not challenging to obtain the e-book Developability Of Biotherapeutics: Computational ApproachesFrom CRC Press Also guide is not alreadied existing yet out there, you to look for in this web site. As just what you could locate of this Developability Of Biotherapeutics: Computational ApproachesFrom CRC Press It will truly ease you to be the initial one reading this e-book Developability Of Biotherapeutics: Computational ApproachesFrom CRC Press and also get the perks.

Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Developability of Biotherapeutics: Computational ApproachesFrom CRC Press



Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Download PDF Ebook Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Biopharmaceuticals are emerging as frontline medicines to combat several life-threatening and chronic diseases. However, such medicines are expensive to develop and produce on a commercial scale, contributing to rising healthcare costs. Developability of Biotherapeutics: Computational Approaches describes applications of computational and molecular modeling techniques that improve the overall process of discovery and development by removing empiricism.

The concept of developability involves making rational choices at the pre-clinical stages of biopharmaceutical drug development that could positively impact clinical outcomes. The book also addresses a general lack of awareness of the many different contributions that computation can make to biopharmaceutical drug development.

This informative and practical reference is a valuable resource for professionals engaged in industrial research and development, scientists working with regulatory agencies, and pharmacy, medicine, and life science students and educators. It focuses primarily on the developability of monoclonal antibody candidates, but the principles described can also be extended to other modalities such as recombinant proteins, fusion proteins, antibody drug conjugates and vaccines.

The book is organized into two sections. The first discusses principles and applications of computational approaches toward discovering and developing biopharmaceutical drugs. The second presents best practices in developability assessments of early-stage biopharmaceutical drug candidates.

In addition to raising awareness of the promise of computational research, this book also discusses solutions required to improve the success rate of translating biologic drug candidates into products available in the clinic. As such, it is a rich source of information on current principles and practices as well as a starting point for finding innovative applications of computation towards biopharmaceutical drug development.

Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

  • Published on: 2015-11-18
  • Released on: 2015-11-18
  • Format: Kindle eBook
Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

About the Author

Sandeep Kumar, PhD, is a senior principal scientist at Pfizer, Inc. in the Biotherapeutics Pharmaceutical Sciences group, working on computational modeling and developability risk assessments of a wide variety of biotherapeutic drug candidates, including monoclonal antibodies, antibody-based therapeutics, fusion proteins, vaccines, and antibody–drug conjugates. He earned his PhD in computational biophysics from the Molecular Biophysics Unit of the Indian Institute of Science, Bangalore, India, and performed postdoctoral research on proteins at the National Cancer Institute in Frederick, Maryland, a part of the National Institutes of Health. He has been an assistant professor (research-track) at Georgetown University Medical Center, Washington, DC; an assistant professor at the Indian Institute of Technology, Kanpur; and an associate research scientist at Johns Hopkins University, Baltimore, Maryland. He has more than 17 years of experience in computational protein sciences. He has contributed more than 60 research papers, review articles, and book chapters, has delivered more than 40 invited talks, and has chaired sessions of several conferences. He has won several fellowships and awards, including a Fogarty visiting scientist fellowship at NIH and the 2014 Ebert Prize from the American Pharmacists Association. He has also mentored several graduate students and postdoctoral scientists.

Satish Kumar Singh, PhD, is a research fellow at Pfizer, Inc. in the Biotherapeutics Pharmaceutical Sciences group, and an adjunct professor of the Department of Physical Pharmaceutical Chemistry at Uppsala University in Sweden. His responsibilities include leading formulation, product, and process development activities for biologics and therapeutic vaccines. He earned his PhD in chemical engineering from Kansas State University. He has more than 25 years of industrial experience and has published more than 50 peer-reviewed articles with emphasis on the colloidal and physical chemistry of macromolecules. He also holds four patents. He is involved in several professional groups through the American Association of Pharmaceutical Scientists and the USP, was chair of the Protein Aggregation and Immunogenicity Focus group, and is a frequently invited speaker at various conferences and symposia.


Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Where to Download Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Most helpful customer reviews

0 of 0 people found the following review helpful. A very dense, but very readable (and nicely visual) book on biopharmaceuticals By Boris Excellent text on developability. This book is surprising in the breadth and depth that it covers, especially on improving a business' odds of success and de-risking the biologics pipeline. An excellent list of top-flight authors take on the chapters.

See all 1 customer reviews... Developability of Biotherapeutics: Computational ApproachesFrom CRC Press


Developability of Biotherapeutics: Computational ApproachesFrom CRC Press PDF
Developability of Biotherapeutics: Computational ApproachesFrom CRC Press iBooks
Developability of Biotherapeutics: Computational ApproachesFrom CRC Press ePub
Developability of Biotherapeutics: Computational ApproachesFrom CRC Press rtf
Developability of Biotherapeutics: Computational ApproachesFrom CRC Press AZW
Developability of Biotherapeutics: Computational ApproachesFrom CRC Press Kindle

Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Developability of Biotherapeutics: Computational ApproachesFrom CRC Press
Developability of Biotherapeutics: Computational ApproachesFrom CRC Press

Tidak ada komentar:

Posting Komentar